Börje Ekholm Proposed as New Chair of Sobi Board of Directors Ahead of 2027 AGM

The Nomination Committee of Swedish Orphan Biovitrum AB (Sobi) has announced its proposal to elect Börje Ekholm as a new board member and Chair of the Board. This appointment is scheduled for consideration at the company's 2027 Annual General Meeting (AGM).

Current Board Chair David Meek has informed the Nomination Committee that he will not stand for re-election at the upcoming 2027 AGM. Meek, who has served as a board member and Chair since December 2024, will continue fulfilling his duties for the remainder of his term until May 2027.

Leadership Background and Experience

Börje Ekholm brings over three decades of international business, technology, and investment management leadership. His career background includes serving as CEO of Ericsson, Patricia Industries, and Investor AB. Additionally, his governance experience features roles as Chair of Trimble Inc., board assignments at Nasdaq Inc., Alibaba, Husqvarna, and Scania, alongside advisory positions with Mars Inc. and Ericsson.

Historically, Ekholm was involved in the creation of Sobi during his tenure at Investor AB through the merger of Biovitrum and Swedish Orphan International, offering him an early owner-perspective familiarity with the enterprise.

Nomination Details and Next Steps

• Current Status: Proposed nomination by the Sobi Nomination Committee ahead of the 2027 AGM.
• Transition Timeline: David Meek remains active as Chair until May 2027.
• Complete Proposals: The Nomination Committee will release its complete governance proposals publicly prior to the 2027 AGM.

Stakeholders and interested parties can verify official announcements and updates directly through Sobi's investor relations portal or via official regulatory filings published on Nasdaq Stockholm.